Comparative analyses of tissue samples from COVID-19 patients and control groups have demonstrated significantly elevated TNF-α expression, suggesting that this signaling pathway is a key driver of angiogenic responses in individuals infected by SARS-CoV-2 [48] (Figure 3). This evidence concerns the gene TNF and COVID-19.